Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
35.26
+1.17 (3.43%)
At close: Jun 26, 2026, 4:00 PM EDT
34.40
-0.86 (-2.44%)
Pre-market: Jun 29, 2026, 6:24 AM EDT
Celldex Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $42 | Buy | Reiterates | $42 | +19.12% | Jun 15, 2026 |
| Wolfe Research | Wolfe Research | Buy Maintains $51 → $44 | Buy | Maintains | $51 → $44 | +24.79% | Jun 15, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $44 | Buy | Maintains | $44 | +24.79% | Jun 12, 2026 |
| UBS | UBS | Buy Maintains $38 → $45 | Buy | Maintains | $38 → $45 | +27.62% | Jun 10, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $38 → $54 | Buy | Reiterates | $38 → $54 | +53.15% | May 13, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $67 | Buy | Reiterates | $67 | +90.02% | May 8, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $34 → $38 | Hold | Maintains | $34 → $38 | +7.77% | May 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $62 | Buy | Maintains | $62 | +75.84% | May 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.